Nymox Pharmaceutical Corp (NYMX): James George Robinson , director of Nymox Pharmaceutical Corp purchased 28,010 shares on May 10, 2016. The Insider buying transaction was reported by the company on May 13, 2016 to the Securities and Exchange Commission. The shares were purchased at $2.32 per share for a total value of $64,833.20 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 6, 2016, James George Robinson (director) purchased 6,990 shares at $2.37 per share price.
Nymox Pharmaceutical Corporation (NYMX) witnessed a volatile trading activity on Tuesday May 10, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $2.33 and reached the intraday high at $2.33. The bulls started the profit booking and pushed the shares to intraday low of $2.2501. The trading session was marked by a volume range of 44,629 shares exchanging hands. The 52-week high of the shares is $4.37 and the 52-week low is $1.13. The market cap of the company stands at $99 M and there are 4,29,88,419 shares in public circulation.